APA (7th ed.) Citation

Li, X., Zhu, Y., Zhang, G., Huang, J., & Pei, L. (2021). The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials. Journal of Ovarian Research, 14(1), 1. https://doi.org/10.1186/s13048-021-00790-4

Chicago Style (17th ed.) Citation

Li, Xin-Ru, Yi Zhu, Guo-Nan Zhang, Jian-Ming Huang, and Li-Xia Pei. "The Impact of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer: An Updated Meta-analysis of Randomized Clinical Trials." Journal of Ovarian Research 14, no. 1 (2021): 1. https://doi.org/10.1186/s13048-021-00790-4.

MLA (9th ed.) Citation

Li, Xin-Ru, et al. "The Impact of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer: An Updated Meta-analysis of Randomized Clinical Trials." Journal of Ovarian Research, vol. 14, no. 1, 2021, p. 1, https://doi.org/10.1186/s13048-021-00790-4.